Medical Communications

Showing 15 posts of 6408 posts found.

celgene_1_02

Celgene’s COO heads to the exit

April 3, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing Celgene, Mark Alles, Scott Smith, biotech, drugs, pharma, pharmaceutical

Celgene has had a rough six months, its share price since the beginning of October has dropped from $146 to …
theresa_may_-_credit_arno_mikkor

May hints at providing long-term funding plan for NHS

March 28, 2018 Medical Communications, Research and Development Conservatives, NHS, Theresa May, UK government, biotech, drugs, pharma, pharmaceutical

After the news broke earlier in the week of a group of nearly 100 MPs calling for a parliamentary commission …
brexit-referendum-uk-1468255193y2p

Brexit Health Alliance: Brexit and the impact on patient access to medicines

March 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brexit Health Alliance, brexit, feature, market access, pharma

On behalf of the Brexit Health Alliance, Sarah Collen, Senior Policy Manager at NHS Confederation, details the potential negative fallout …
eu-flag-2108026_960_720

Six reasons why UK pharma has more to gain, than fear, from Brexit

March 26, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, biotech, brexit, drugs, hard Brexit, pharma, pharmaceutical

There are good reasons to think exiting the EU represents a major opportunity for this dynamic and world-leading industry, argues …

May faces pressure for cross-party talks over NHS future

March 26, 2018 Medical Communications, Sales and Marketing NHS, Theresa May, UK government, biotech, drugs, pharma, pharmaceutical

A group of close to 100 MPs have demanded that Theresa May set up a parliamentary commission to plot the …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Celgene, Lundbeck, Marijuana, Novartis, Roche, Vertex, brexit, cannabis, multiple sclerosis, neuroscience, pharma

As me move startlingly quickly towards Easter, it’s time for another Top Ten rundown. This week, Celgene surprised the industry …
suboxone

Indivior rocked by loss of patent case

March 23, 2018 Medical Communications, Sales and Marketing Alvogen, biotech, drugs, indivior, opioid, pharma, pharmaceutical

Indivior has been dealt a hammer blow after US District Court for the District of Delaware found in favour of …
medical_waste

Medical waste in India to hit 775.5 tonnes daily by 2022, study suggests

March 23, 2018 Manufacturing and Production, Medical Communications India, medical waste, pharma

A new report has shed light on the worrying state of medicinal wastage in India, indicating that the levels of …
cancer-389921_960_720

Lifestyle factors to blame for 38% of cancers

March 23, 2018 Medical Communications Cancer, Cancer Research UK, UK government, biotech, drugs, pharma, pharmaceutical

A new study by Cancer Research UK has found that more than 135,500 cases of cancer every year in the …
gsk_boronia_australia

GSK withdraws from running for Pfizer Consumer Health

March 23, 2018 Medical Communications, Sales and Marketing GSK, Pfizer, Pfizer Consumer Health, biotech, drugs, pharma, pharmaceutical

GSK has announced that it has decided to pull out of the race to acquire Pfizer’s Consumer Health business, ending …
architect_of_the_capitol_2

US “right to try” legislation passes after initial defeat

March 22, 2018 Medical Communications, Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma

The controversial and much-discussed “right to try” bill has been passed in the US House of Representatives, quickly rebounding after …
brexit_flag_0

Independent committee report seeks Brexit healthcare clarity

March 21, 2018 Medical Communications, Research and Development ABPI, UK, biotech, brexit, drugs, pharma, pharmaceutical

An independent report, entitled Brexit – Medicines, Medical Devices and Substances of Human Origin and written by the Health and …
takeda_global_hq

Takeda completes construction of new global headquarters in Tokyo

March 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, pharma, tokyo

Japan’s biggest pharmaceutical firm Takeda has announced the completion of construction of its new global headquarters in the country’s capital …
The Gateway to Local Adoption Series

Latest content